Regent Pacific Group Ltd (hkse:00575) Share Price

Company Profile

Business description
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
Contact
5 Queen's Road Central
8th Floor, Henley Building
Hong Kong
HKG
T: +852 25146111
https://www.endurancerp.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
16

Recommended

Real estate share remains cheap despite losing airport legal battle.

Yingqi Tan, CFA | 12 June 2026

The ChatGPT maker joined Anthropic in filing a confidential S-1 with the SEC, teeing up a future IPO.

Jacob Robbins | 11 June 2026

We see a solid business case for a merger, but not without hurdles, including Tesla shareholders’ concern about SpaceX’s valuation.

Seth Goldstein, CFA | 11 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,006.10	29.10	0.32%
CAC 40	8,318.41	117.62	1.43%
DAX 40	24,491.38	281.67	1.16%
Dow JONES (US)	50,848.75	929.97	1.86%
FTSE 100	10,398.61	94.73	0.92%
HKSE	24,718.10	468.81	1.93%
NASDAQ	25,809.66	640.16	2.54%
Nikkei 225	66,020.04	1,802.77	2.81%
NZX 50 Index	13,393.87	191.71	1.45%
S&P 500	7,394.30	0.00	0.00%
S&P/ASX 200	8,804.00	30.50	0.35%
SSE Composite Index	4,031.51	44.50	1.12%